Date
Insider
Company
Owned Shares
Shares Traded
Price
Net Total
SELL
4 May 2023Ticho Barry
Chief Medical Officer, Officer
Stoke Therapeutics, Inc.
(STOK)
55,895-1%
653
$10.00
$6,530.00
SELL
1 May 2023Ticho Barry
Chief Medical Officer, Officer
Stoke Therapeutics, Inc.
(STOK)
56,548-49%
55,177
$10.06
$555,267.06
SELL
3 Feb 2023Ticho Barry
Chief Medical Officer, Officer
Stoke Therapeutics, Inc.
(STOK)
111,725-10%
12,998
$10.02
$130,236.44
SELL
31 Jan 2023Ticho Barry
Chief Medical Officer, Officer
Stoke Therapeutics, Inc.
(STOK)
124,723-4%
6,172
$10.01
$61,810.14
SELL
3 Jan 2022Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
2,303-62%
3,800
$23.07
$87,666.13
SELL
1 Dec 2021Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
2,500-69%
5,700
$24.44
$139,329.61
SELL
1 Nov 2021Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0-100%
5,700
$24.03
$136,956.48
SELL
1 Oct 2021Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0-100%
5,700
$24.83
$141,505.92
SELL
1 Sep 2021Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0-100%
5,700
$26.00
$148,222.80
SELL
2 Aug 2021Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0-100%
5,700
$28.87
$164,554.44
SELL
13 Jul 2021Ticho Barry
Chief Medical Officer, Officer
Stoke Therapeutics, Inc.
(STOK)
134,195-24%
43,166
$32.75
$1,413,654.00
SELL
1 Jul 2021Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0-100%
5,700
$33.33
$189,986.70
SELL
1 Jun 2021Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0-100%
575
$39.43
$22,669.49
SELL
1 Mar 2021LEVIN ARTHUR A
Director
Stoke Therapeutics, Inc.
(STOK)
4,957-71%
12,500
$60.79
$759,841.10
SELL
22 Feb 2021Tulipano Stephen J
CFO, Officer
Stoke Therapeutics, Inc.
(STOK)
602-98%
30,000
$58.86
$1,765,895.80
SELL
19 Feb 2021TZIANABOS ARTHUR
Director
Stoke Therapeutics, Inc.
(STOK)
0-100%
10,000
$60.67
$606,652.00
SELL
4 Jan 2021Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0-100%
5,732
$58.96
$337,985.40
SELL
28 Dec 2020Liau Gene
EVP Research & Preclinical Dev, Officer
Stoke Therapeutics, Inc.
(STOK)
24,251-18%
5,344
$62.93
$336,297.16
SELL
21 Dec 2020Ticho Barry
Chief Medical Officer, Officer
Stoke Therapeutics, Inc.
(STOK)
174,053-0%
1,365
$57.62
$78,654.05
SELL
17 Dec 2020Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0-100%
50,000
$60.00
$3,000,000.00
SELL
17 Dec 2020Kaye Edward M. MD
CEO, Director, Officer
Stoke Therapeutics, Inc.
(STOK)
0-100%
25,000
$60.00
$1,500,000.00
SELL
1 Dec 2020Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
2,981-65%
5,700
$49.84
$284,079.62
SELL
27 Nov 2020Kaye Edward M. MD
CEO, Director, Officer
Stoke Therapeutics, Inc.
(STOK)
25,000-32%
12,152
$50.00
$607,600.00
SELL
25 Nov 2020Kaye Edward M. MD
CEO, Director, Officer
Stoke Therapeutics, Inc.
(STOK)
37,152-25%
12,848
$50.00
$642,400.00
BUY
24 Nov 2020Harrison Seth Loring
Director, 10% Owner
Stoke Therapeutics, Inc.
(STOK)
17,161,712+2%
375,000
$39.00
$14,625,000.00
BUY
24 Nov 2020Apple Tree Partners IV, L.P.
10% Owner
Stoke Therapeutics, Inc.
(STOK)
17,161,712+2%
375,000
$39.00
$14,625,000.00
SELL
23 Nov 2020TZIANABOS ARTHUR
Director
Stoke Therapeutics, Inc.
(STOK)
15,700-56%
20,000
$46.03
$920,565.70
SELL
10 Nov 2020Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0-100%
50,000
$45.00
$2,250,000.00
SELL
2 Nov 2020Tulipano Stephen J
CFO, Officer
Stoke Therapeutics, Inc.
(STOK)
16,929-80%
70,000
$39.00
$2,729,938.50
SELL
2 Nov 2020Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
2,536-69%
5,700
$37.21
$212,109.89
SELL
16 Oct 2020Liau Gene
EVP Research & Preclinical Dev, Officer
Stoke Therapeutics, Inc.
(STOK)
20,725-64%
37,851
$38.16
$1,444,205.80
SELL
13 Oct 2020Liau Gene
EVP Research & Preclinical Dev, Officer
Stoke Therapeutics, Inc.
(STOK)
13,500-10%
1,649
$40.00
$65,960.00
SELL
1 Oct 2020Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
2,300-71%
5,700
$34.54
$196,900.53
SELL
8 Sep 2020Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0-100%
47,919
$30.00
$1,437,570.00
SELL
1 Sep 2020Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
700-89%
5,700
$27.74
$158,112.62
SELL
28 Aug 2020Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0-100%
2,081
$30.00
$62,430.00
SELL
3 Aug 2020Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0-100%
5,700
$24.73
$140,943.33
SELL
16 Jul 2020Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0-100%
1,900
$25.06
$47,614.00
SELL
7 Jul 2020Walker Robin A.
Chief Legal Officer, CCO & Sec, Officer
Stoke Therapeutics, Inc.
(STOK)
0-100%
941
$22.50
$21,172.50
SELL
7 Jul 2020Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0-100%
913
$22.41
$20,456.86
SELL
1 Jul 2020Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0-100%
3,800
$23.15
$87,967.73
SELL
1 Jun 2020Ticho Barry
Chief Medical Officer, Officer
Stoke Therapeutics, Inc.
(STOK)
173,027-0%
1,365
$27.39
$37,386.70
SELL
1 Jun 2020Liau Gene
EVP Research & Preclinical Dev, Officer
Stoke Therapeutics, Inc.
(STOK)
22,605-46%
20,000
$26.35
$527,036.80
SELL
1 Jun 2020Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
500-80%
2,107
$27.18
$57,263.26
SELL
22 May 2020Liau Gene
EVP Research & Preclinical Dev, Officer
Stoke Therapeutics, Inc.
(STOK)
13,500-35%
7,500
$30.00
$225,000.00
SELL
2 Mar 2020Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
15,995-75%
49,143
$25.89
$1,272,549.20
SELL
8 Nov 2019RTW INVESTMENTS, LP
10% Owner
Stoke Therapeutics, Inc.
(STOK)
3,544,248-0%
16,434
$28.70
$471,631.16
BUY
4 Nov 2019RTW INVESTMENTS, LP
10% Owner
Stoke Therapeutics, Inc.
(STOK)
3,560,682+3%
104,873
$29.24
$3,066,843.20
BUY
30 Oct 2019RTW INVESTMENTS, LP
10% Owner
Stoke Therapeutics, Inc.
(STOK)
3,455,809+2%
68,783
$28.59
$1,966,612.90
BUY
1 Oct 2019RTW INVESTMENTS, LP
10% Owner
Stoke Therapeutics, Inc.
(STOK)
3,387,026+0%
31,560
$21.96
$693,029.25
BUY
21 Jun 2019Harrison Seth Loring
Director, 10% Owner
Stoke Therapeutics, Inc.
(STOK)
16,786,712+9%
1,388,889
$18.00
$25,000,002.00
BUY
21 Jun 2019Apple Tree Partners IV, L.P.
10% Owner
Stoke Therapeutics, Inc.
(STOK)
16,786,712+9%
1,388,889
$18.00
$25,000,002.00
BUY
19 Jun 2019RTW INVESTMENTS, LP
10% Owner
Stoke Therapeutics, Inc.
(STOK)
3,355,466+19%
555,556
$18.00
$10,000,008.00